✦ LIBER ✦

Estimating the cost-effectiveness of tirofiban for acute coronary syndrome patients managed in a relatively low interventional setting: The United Kingdom

✍ Scribed by Ameet Bakhai; Christos Alexopoulos; David Goldsman; Evo Alemao; Robert Deuson; John Cook; Marcus D. Flather

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV89 PRASUGREL COST-EFFECTIVE RELATIVE

✍ A Davies; M Sculpher; C Schmitt; A Barrett; J Baird; G Zanotti; A Bakhai 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Cost effectiveness analysis of ticagrelo

✍ Polanco, A.C.; Ascencio, I.S.I.; Almeida, E.; Soto, H.; Salazar, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCV101 IS PRASUGREL COST-EFFECTIVE RELAT

✍ A Davies; M Sculpher; C Schmitt; A Barrett; J Clouth; McCollam PL; A Bakhai 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PCV74 ONE-YEAR COST-EFFECTIVENESS OF CYT

✍ SL Charland; B Agatep; D Malone; E Stanek 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Protocol for a randomised controlled tri

✍ Heidi Cate, Debi Bhattacharya, Allan Clark, Richard Fordham, Caitlin Notley, Dav 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 559 KB

Cost-Effectiveness of Coronary Computed

✍ Virginia L. Priest; Paul A. Scuffham; Rory Hachamovitch; Thomas H. Marwick 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 502 KB